ETFs With Alexion Pharmaceuticals, Inc. (ALXN) Exposure
The following ETFs maintain significant exposure to Alexion Pharmaceuticals, Inc. (ALXN); each of the following funds counts ALXN among its top ten individual holdings. Note that percentages in the table reflect weightings at the beginning of the current month, and are subject to change.
To see a complete breakdown of any of the ETFs included in the table below, including sector, market cap, and country allocations, click on the ticker symbol.
| Ticker | ETF | ETFdb Category | Expense Ratio | Weighting |
|---|---|---|---|---|
| IBB | Nasdaq Biotechnology | Health & Biotech Equities |
|
7.32% |
| FBT | NYSE Arca Biotechnology Index Fund | Health & Biotech Equities |
|
5.54% |
| BBH | Market Vectors Biotech ETF | Health & Biotech Equities |
|
5.38% |
| PBE | Dynamic Biotech &Genome | Health & Biotech Equities |
|
5.38% |
| FXH | Health Care AlphaDEX | Health & Biotech Equities |
|
2.77% |
| PTH | Dynamic Healthcare | Health & Biotech Equities |
|
2.65% |
| PDP | DWA Technical Leaders Portfolio | All Cap Equities |
|
2.16% |
| VOT | Mid-Cap Growth ETF | Mid Cap Growth Equities |
|
1.25% |
| IWP | Russell Midcap Growth Index | Mid Cap Growth Equities |
|
0.79% |
| VO | Mid-Cap ETF | Mid Cap Blend Equities |
|
0.61% |
| VXF | Extended Market ETF | Mid Cap Blend Equities |
|
0.52% |
| WXSP | Wilshire 4500 Completion ETF | All Cap Equities |
|
0.52% |
© 2012 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.
